GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sam-A-Pharm Co Ltd (XKRX:009300) » Definitions » Research & Development

Sam-A-Pharm Co (XKRX:009300) Research & Development : ₩5,241 Mil (TTM As of Mar. 2025)


View and export this data going back to 2000. Start your Free Trial

What is Sam-A-Pharm Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Sam-A-Pharm Co's Research & Development for the three months ended in Mar. 2025 was ₩979 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ₩5,241 Mil.


Sam-A-Pharm Co Research & Development Historical Data

The historical data trend for Sam-A-Pharm Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sam-A-Pharm Co Research & Development Chart

Sam-A-Pharm Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,680.84 3,829.31 3,770.75 6,397.60 5,420.68

Sam-A-Pharm Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,159.26 1,375.92 1,006.52 1,878.98 979.46

Sam-A-Pharm Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩5,241 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sam-A-Pharm Co  (XKRX:009300) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Sam-A-Pharm Co Research & Development Related Terms

Thank you for viewing the detailed overview of Sam-A-Pharm Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Sam-A-Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
265 Ojeon-Dong, Uiwang-Si, KOR, 437-832
Sam-A-Pharm Co Ltd is a South Korea based company engages in the manufacturing of pharmaceutical products. Its products include medicines for cold and fever, inflammatory, allergy, nutrition, and respiratory and digestive systems.

Sam-A-Pharm Co Headlines

No Headlines